Wataru Kamoto

Advising Shimadzu Corporation on its investment in U-Medico Inc., a CRO startup from Osaka University that specializes in biomedical supplies, including antibody medicines and gene therapy pharmaceuticals.

Advising Shimadzu Corporation on its investment in Sepragen Corporation, a leading manufacturer of bioprocess chromatography systems used in the production of biopharmaceuticals.

 Advising a Dutch subsidiary of a Japanese power producer on Japanese aspects of financing and project company restructuring matters related to its equity stake in a European company specializing in geothermal power technology.

Advising a large U.S. industrial chemicals manufacturer on its acquisition of a Japanese company specializing in chemical products.

Advising Virbac on its agreement with ORIX Corporation for the €280 million acquisition of its Japanese animal health subsidiary Sasaeah Holdings Co., Ltd. 

Advising Shimadzu Corporation on its acquisition of the catalytic microreactor business for gas chromatography from Activated Research Company, a U.S.-based energy transition startup.

Advising Daicel Corporation on its strategic investment in PharmaJet, a U.S.-based company that develops needle- and syringe-free device systems for intradermal injections.

Advising Samvardhana Motherson International Limited on its purchase of an 81% stake in Yachiyo Industry Co., Ltd., a TSE-listed subsidiary of Honda Motors Co., Ltd. 

Advising Covestro AG, one of the world’s leading manufacturers of high-quality plastics and their components, on the sale of its additive manufacturing business to US-Israeli Stratasys Group.

Advised a Japanese consumer technology company on JP¥704 million third party share allotment requiring appointment of third party committee to determine reasonableness.

Advised a Japanese medical manufacturer on the issuance of JP¥4.3 billion third party share allotment requiring appointment of third party committee to determine reasonableness.

Advised a Japanese pharmaceutical company on the issuance of JP¥5.4 billion third party share allotment requiring appointment of third party committee to determine reasonableness.

Advising Chubu Electric Power Co., Inc. on its acquisition of a 50% stake in a German geothermal power project and a joint venture with Marubeni Corporation.

Advising a Japanese company on its joint venture with Japan's largest parcel delivery company.

Advising a Japanese company on its acquisition of its subsidiary.

Represented Synopsys in connection with its acquisition of the semiconductor and flat panel display solutions business from BISTel.

Advising a global risk management solutions company on the wind down and solvent liquidation of operations in Japan.

Advising a global software solutions company on the wind down and solvent liquidation of operations in Japan.

Advising a Japanese company on the U.S. anti-trust investigation.*

Advising a Japanese listed company on a merger control filing in foreign countries.*

Advising a U.S. fund on making investments into various Japanese companies.*

Advising a global company on dealing with an anti-trust related procedure by the Japanese Fair Trade Commission.*

Advising various foreign companies on merger control filings with the Japanese Fair Trade Commission.*